Falls and Cardiovascular Events in Pacemaker Patients
1 other identifier
interventional
87
1 country
8
Brief Summary
The purpose of this study is to document the number of falls and fractures in Sinus Node Disease (SND) patients.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P50-P75 for phase_4
Started Aug 2009
Longer than P75 for phase_4
8 active sites
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
August 1, 2009
CompletedFirst Submitted
Initial submission to the registry
August 6, 2009
CompletedFirst Posted
Study publicly available on registry
December 23, 2009
CompletedPrimary Completion
Last participant's last visit for primary outcome
January 1, 2014
CompletedStudy Completion
Last participant's last visit for all outcomes
January 1, 2014
CompletedJuly 3, 2025
September 1, 2017
4.4 years
August 6, 2009
June 30, 2025
Conditions
Keywords
Outcome Measures
Primary Outcomes (1)
number of falls in SND patients during one year before versus one year after implantation of a MVPTM pacemaker
2 years
Secondary Outcomes (6)
fracture risk profile and 10-yr fracture risk based on the WHO FRAX index
2 years
fall rate of recurrent fallers
2 years
fracture rate
2 years
combined CV and mortality endpoint
2 years
any of the individual cardiovascular endpoints
2 years
- +1 more secondary outcomes
Study Arms (1)
Study group
OTHERFalls before versus after pacemaker implant
Interventions
Questionnaire at time of Implantation and 12 months after pacemaker implantation to collect * History of falls and fractures during the 12 months before pacemaker implantation * Risk markers for falls based on FRAX risk calculator (age, gender, weight, height, history of previous fracture, family history of hip fracture, current smoking habits, glucocorticosteroid intake, rheumatoid arthritis, secondary osteoporosis, alcohol intake) * History of falls and fractures during the 12 months after pacemaker implantation * Medical and Arrhythmia History * Cardiovascular Events * Cardiovascular Medication * Device programming information
Eligibility Criteria
You may qualify if:
- Sinus Node Disease (SND) treated with a pacemaker with MVP (TM) mode according to ESC 2007 guidelines (SND as primary indication for pacemaker implant, implant within past two weeks)
- Geographic stability and availability for follow-up at the study center for the length of the study
- Willingness and Ability to sign Informed Consent
You may not qualify if:
- Age less than 50 years
- Impaired cognitive function (such as Alzheimer's disease)
- permanent AV Block II and III
- Persistent atrial fibrillation
- Life expectancy less than two years
- Enrollment or intended participation in another clinical trial during the course of this study
- Subject is pregnant or breastfeeding
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (8)
Zuger Kantonsspital
Baar, Switzerland
University Hospital Basel
Basel, Switzerland
SG Spitalregion RWS
Kanton Sankt Gallen, Switzerland
Kantonsspital St. Gallen
Sankt Gallen, Switzerland
CHCVS - Hôpital de SION
Sion, Switzerland
Luzerner Kantonsspital
Sursee, Switzerland
Stadtspital Waid
Zurich, Switzerland
USZ - University Hospital Zurich
Zurich, Switzerland
Related Publications (1)
Brenner R, Ammann P, Yoon SI, Christen S, Hellermann J, Girod G, Knaus U, Duru F, Krasniqi N, Ramsay D, Sticherling C, Lippuner K, Kuhne M. Reduction of falls and fractures after permanent pacemaker implantation in elderly patients with sinus node dysfunction. Europace. 2017 Jul 1;19(7):1220-1226. doi: 10.1093/europace/euw156.
PMID: 27702858BACKGROUND
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Study Officials
- PRINCIPAL INVESTIGATOR
Michael Kuehne, Dr. med.
University Hospital, Basel, Switzerland
- STUDY DIRECTOR
Ray Moser, PhD
Medtronic (Schweiz) AG - Münchenbuchsee - Switzerland
Study Design
- Study Type
- interventional
- Phase
- phase 4
- Allocation
- NA
- Masking
- NONE
- Purpose
- PREVENTION
- Intervention Model
- SINGLE GROUP
- Sponsor Type
- INDUSTRY
- Responsible Party
- SPONSOR
Study Record Dates
First Submitted
August 6, 2009
First Posted
December 23, 2009
Study Start
August 1, 2009
Primary Completion
January 1, 2014
Study Completion
January 1, 2014
Last Updated
July 3, 2025
Record last verified: 2017-09
Data Sharing
- IPD Sharing
- Will not share
there is no plan